ATE332690T1 - Perindopril enthaltende pharmazeutische zusammensetzung mit oraler dispersion - Google Patents

Perindopril enthaltende pharmazeutische zusammensetzung mit oraler dispersion

Info

Publication number: ATE332690T1
Authority: AT; Austria
Prior art keywords: pharmaceutical composition; composition containing; dispersion pharmaceutical; oral dispersion; containing perindopril
Prior art date: 2002-01-23

Application number

AT03731736T

Other languages

English (en)

Inventor

Patrick Wuthrich

Herve Rolland

Marc Julien

Original Assignee

Servier Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-01-23

Filing date

2003-01-22

Publication date

2006-08-15

2003-01-22 Application filed by Servier Lab filed Critical Servier Lab

2006-08-15 Application granted granted Critical

2006-08-15 Publication of ATE332690T1 publication Critical patent/ATE332690T1/de

Links

239000006185 dispersion Substances 0.000 title 1
IPVQLZZIHOAWMC-QXKUPLGCSA-N perindopril Chemical compound C1CCC[C@H]2C[C@@H](C(O)=O)N(C(=O)[C@H](C)N[C@@H](CCC)C(=O)OCC)[C@H]21 IPVQLZZIHOAWMC-QXKUPLGCSA-N 0.000 title 1
229960002582 perindopril Drugs 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/556—Angiotensin converting enzyme inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Cardiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Heart & Thoracic Surgery (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Physiology (AREA)
Nutrition Science (AREA)
Zoology (AREA)
Vascular Medicine (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Hospice & Palliative Care (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT03731736T 2002-01-23 2003-01-22 Perindopril enthaltende pharmazeutische zusammensetzung mit oraler dispersion ATE332690T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR0200790A FR2834893B1 (fr)	2002-01-23	2002-01-23	Composition pharmaceutique orodispersible de perindopril

Publications (1)

Publication Number	Publication Date
ATE332690T1 true ATE332690T1 (de)	2006-08-15

Family

ID=27589554

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT03731736T ATE332690T1 (de)	2002-01-23	2003-01-22	Perindopril enthaltende pharmazeutische zusammensetzung mit oraler dispersion

Country Status (26)

Country	Link
US (3)	US20050106237A1 (de)
EP (1)	EP1467750B1 (de)
JP (1)	JP4090997B2 (de)
KR (1)	KR100588224B1 (de)
CN (1)	CN1658898B (de)
AR (1)	AR038305A1 (de)
AT (1)	ATE332690T1 (de)
AU (1)	AU2003215708B2 (de)
BR (1)	BRPI0307048B1 (de)
CA (1)	CA2473205C (de)
CY (1)	CY1105655T1 (de)
DE (1)	DE60306747T2 (de)
DK (1)	DK1467750T3 (de)
EA (1)	EA007181B1 (de)
ES (1)	ES2268372T3 (de)
FR (1)	FR2834893B1 (de)
GE (1)	GEP20063821B (de)
MA (1)	MA27099A1 (de)
MX (1)	MXPA04007195A (de)
NO (1)	NO333723B1 (de)
NZ (1)	NZ533821A (de)
PL (1)	PL205473B1 (de)
PT (1)	PT1467750E (de)
UA (1)	UA78279C2 (de)
WO (1)	WO2003061691A1 (de)
ZA (1)	ZA200405009B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2005067887A2 (en) *	2004-03-24	2005-07-28	Actavis Group	Formulations of ramipril
DE102004019845A1 (de) *	2004-03-29	2005-10-20	Krka Tovarna Zdravil D D	Verfahren zur Herstellung einer festen pharmazeutischen Zusammensetzung
SK50252005A3 (sk) *	2005-03-22	2006-10-05	Vúlm, A.S.	Farmaceutický prípravok obsahujúci perindopril erbumín, spôsob jeho prípravy a stabilizácie
GB0518129D0 (en) *	2005-09-06	2005-10-12	Arrow Int Ltd	Ramipril formulation
US20070098782A1 (en) *	2005-10-28	2007-05-03	Selamine Limited	Ramipril Formulation
GB2431579A (en) *	2005-10-28	2007-05-02	Arrow Int Ltd	Ramipril formulations
GB0624087D0 (en) *	2006-12-01	2007-01-10	Selamine Ltd	Ramipril combination salt
GB0624090D0 (en) *	2006-12-01	2007-01-10	Selamine Ltd	Ramipril amine salts
GB0624084D0 (en) *	2006-12-01	2007-01-10	Selamine Ltd	Ramipril amino acid salts
LT2886108T (lt) *	2013-12-23	2019-03-25	Dr. Falk Pharma Gmbh	Optimizuota farmacinė kompozicija, skirta stemplės uždegiminių pakitimų gydymui
US20170042806A1 (en) *	2015-04-29	2017-02-16	Dexcel Pharma Technologies Ltd.	Orally disintegrating compositions
US10076494B2 (en)	2016-06-16	2018-09-18	Dexcel Pharma Technologies Ltd.	Stable orally disintegrating pharmaceutical compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3506276C1 (de) *	1985-02-22	1986-04-24	Meggle Milchindustrie Gmbh & Co Kg, 8094 Reitmehring	Direkttablettiermittel
TW391880B (en) *	1994-01-31	2000-06-01	Yamanouchi Pharma Co Ltd	An oral soluble type compression moulding and its preparation
EP1058538B9 (de) *	1998-03-06	2013-01-02	Aptalis Pharma S.r.l.	Schnell zerfallende tablette
CA2374760A1 (en) *	1999-06-18	2000-12-28	Takeda Chemical Industries, Ltd.	Quickly disintegrating solid preparations
FR2811318B1 (fr) *	2000-07-06	2002-08-23	Adir	Nouvelle forme cristalline gamma du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
EP1175899B1 (de) *	2000-07-27	2007-08-29	Roquette FrÀ¨res	Granulat bestehend aus Stärke und Laktose
US6651768B2 (en) *	2000-11-06	2003-11-25	Bombardier Inc.	Snowmobile engine mount
FR2834889B1 (fr) *	2002-01-18	2004-04-02	Roquette Freres	Forme pharmaceutique solide orodispersible

2002
- 2002-01-23 FR FR0200790A patent/FR2834893B1/fr not_active Expired - Fee Related
2003
- 2003-01-22 DE DE60306747T patent/DE60306747T2/de not_active Expired - Lifetime
- 2003-01-22 US US10/502,479 patent/US20050106237A1/en not_active Abandoned
- 2003-01-22 PL PL370162A patent/PL205473B1/pl unknown
- 2003-01-22 AU AU2003215708A patent/AU2003215708B2/en not_active Ceased
- 2003-01-22 EP EP03731736A patent/EP1467750B1/de not_active Expired - Lifetime
- 2003-01-22 EA EA200400884A patent/EA007181B1/ru not_active IP Right Cessation
- 2003-01-22 GE GE5628A patent/GEP20063821B/en unknown
- 2003-01-22 JP JP2003561634A patent/JP4090997B2/ja not_active Expired - Fee Related
- 2003-01-22 CA CA2473205A patent/CA2473205C/fr not_active Expired - Fee Related
- 2003-01-22 NZ NZ533821A patent/NZ533821A/en not_active IP Right Cessation
- 2003-01-22 UA UA20040806966A patent/UA78279C2/uk unknown
- 2003-01-22 AT AT03731736T patent/ATE332690T1/de active
- 2003-01-22 CN CN038025191A patent/CN1658898B/zh not_active Expired - Fee Related
- 2003-01-22 KR KR1020047011349A patent/KR100588224B1/ko not_active Expired - Fee Related
- 2003-01-22 BR BRPI0307048-4A patent/BRPI0307048B1/pt not_active IP Right Cessation
- 2003-01-22 MX MXPA04007195A patent/MXPA04007195A/es active IP Right Grant
- 2003-01-22 WO PCT/FR2003/000200 patent/WO2003061691A1/fr not_active Ceased
- 2003-01-22 DK DK03731736T patent/DK1467750T3/da active
- 2003-01-22 PT PT03731736T patent/PT1467750E/pt unknown
- 2003-01-22 ES ES03731736T patent/ES2268372T3/es not_active Expired - Lifetime
- 2003-01-23 AR ARP030100195A patent/AR038305A1/es not_active Application Discontinuation
2004
- 2004-06-24 ZA ZA2004/05009A patent/ZA200405009B/en unknown
- 2004-07-06 MA MA27767A patent/MA27099A1/fr unknown
- 2004-08-20 NO NO20043473A patent/NO333723B1/no not_active IP Right Cessation
2006
- 2006-10-10 CY CY20061101450T patent/CY1105655T1/el unknown
2010
- 2010-06-22 US US12/803,207 patent/US20100267799A1/en not_active Abandoned
2011
- 2011-12-05 US US13/311,498 patent/US20120076856A1/en not_active Abandoned

Also Published As

Publication number	Publication date
PL205473B1 (pl)	2010-04-30
MXPA04007195A (es)	2004-10-29
US20050106237A1 (en)	2005-05-19
NZ533821A (en)	2005-08-26
WO2003061691A1 (fr)	2003-07-31
HK1076743A1 (en)	2006-01-27
JP4090997B2 (ja)	2008-05-28
US20100267799A1 (en)	2010-10-21
FR2834893A1 (fr)	2003-07-25
PT1467750E (pt)	2006-11-30
FR2834893B1 (fr)	2004-02-27
EP1467750A1 (de)	2004-10-20
BRPI0307048B1 (pt)	2015-06-30
DE60306747D1 (de)	2006-08-24
NO333723B1 (no)	2013-09-02
CA2473205A1 (fr)	2003-07-31
ES2268372T3 (es)	2007-03-16
MA27099A1 (fr)	2004-12-20
EP1467750B1 (de)	2006-07-12
AU2003215708B2 (en)	2007-07-19
KR100588224B1 (ko)	2006-06-12
NO20043473L (no)	2004-08-20
CY1105655T1 (el)	2010-12-22
GEP20063821B (en)	2006-05-10
CN1658898A (zh)	2005-08-24
DE60306747T2 (de)	2007-08-02
CA2473205C (fr)	2010-05-18
EA200400884A1 (ru)	2004-12-30
KR20040078130A (ko)	2004-09-08
JP2005523256A (ja)	2005-08-04
AU2003215708B8 (en)	2003-09-02
UA78279C2 (en)	2007-03-15
PL370162A1 (en)	2005-05-16
DK1467750T3 (da)	2006-11-13
ZA200405009B (en)	2005-08-31
EA007181B1 (ru)	2006-08-25
CN1658898B (zh)	2012-10-03
US20120076856A1 (en)	2012-03-29
AU2003215708B9 (en)	2003-09-02
BR0307048A (pt)	2004-10-26
AR038305A1 (es)	2005-01-12

Legal Events

Date

Code

Title

Description

2007-05-15

UEP

Publication of translation of european patent specification

Ref document number: 1467750

Country of ref document: EP

Publication	Publication Date	Title
ATE372765T1 (de)	2007-09-15	Feste pharmazeutische formulierungen mit telmisartan
ATE317260T1 (de)	2006-02-15	Pharmazeutische formulierungen mit platinderivaten
PT1501534E (pt)	2006-09-29	Formulacoes farmaceuticas
ATE336264T1 (de)	2006-09-15	Dispergierbare pharmazeutische zusammensetzungen
ATE320807T1 (de)	2006-04-15	Pharmazeutische zusammensetzungen enthaltend tegaserod
ATE307571T1 (de)	2005-11-15	Pharmazeutische formulierung enthaltend bicalutamid
ATE324882T1 (de)	2006-06-15	In der mundhöhle dispergierbare pharmazeutische zusammensetzung mit agomelatin
DE60312049D1 (de)	2007-04-05	Stabilisierte pharmazeutische zusammensetzung enthaltend einen amorphen wirkstoff
DE60317803D1 (de)	2008-01-10	Pharmazeutische zusammensetzungen enthaltend cyclosporin zur oralen verabreichung
ATE327759T1 (de)	2006-06-15	Pharmazeutische zusammensetzung mit verlungerter freisetzung
ATE477814T1 (de)	2010-09-15	Stabile faktor-viii enthaltende pharmazeutische zusammensetzung
ATE324883T1 (de)	2006-06-15	Pharmazeutische zusammensetzung enthaltend lumiracoxib
ATE350016T1 (de)	2007-01-15	Bicalutamid enthaltende pharmazeutische zusammensetzung
DE60306747D1 (de)	2006-08-24	Perindopril enthaltende pharmazeutische zusammensetzung mit oraler dispersion
DE60310526D1 (de)	2007-02-01	Ivabradin enthaltende pharmazeutische zusammensetzung mit oraler dispersion
ATE507831T1 (de)	2011-05-15	Melatonin enthaltende pharmazeutische formulierung
AU2003215708A1 (en)	2003-09-18	Orodispersible pharmaceutical composition comprising perindopril
NO20043633L (no)	2004-10-27	Oral doseringsform for kontrollert medikamentfrigivning
DE10291905D2 (de)	2004-05-27	Pharmazeutische Zusammensetzung
ATE350029T1 (de)	2007-01-15	Pharmazeutische zusammensetzung enthaltend gamma- butyrobetain
ITTO20020672A0 (it)	2002-07-26	Composizioni farmaceutiche contenenti cheto-acidi per somministrazione endoperitoneale
DE60317719D1 (de)	2008-01-03	Kosmetische und pharmazeutische zusammensetzungen mit lycopin
DE10107261B4 (de)	2005-03-10	Pharmazeutische Zusammensetzung
ATE327758T1 (de)	2006-06-15	In der mundhöhle dispergierbare pharmazeutische zusammensetzung mit piribedil
AU2002236132A1 (en)	2003-09-16	Modified release oral pharmaceutical composition